Advertisement

Infection

, Volume 45, Issue 4, pp 459–467 | Cite as

Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008–2014

  • Marta Mascarello
  • Omar Simonetti
  • Anna Knezevich
  • Ludovica Ilaria Carniel
  • Jacopo Monticelli
  • Marina Busetti
  • Paolo Schincariol
  • Lucio Torelli
  • Roberto Luzzati
Original Paper

Abstract

Purpose

The spread of multidrug-resistant bacteria is a worrisome problem worldwide. This study investigated the correlation between antibiotic consumption and antimicrobial resistance trends of the most important bacteria causing bacteremia at the University hospital of Trieste, Italy, from 2008 to 2014.

Methods

Antibiotic consumption (Defined Daily Dose—DDD—per 100 patient/days) and antibiotic resistance (percentage of antibiotic intermediate o resistant isolates) were analyzed independently with linear correlation by year. Potential correlations between antibiotic consumption and bacteria resistance rates were investigated through the Pearson’s correlation.

Results

The overall consumption of antibiotic grew from 80 to 97 DDD 100 patient/days (p = 0.005) during the study period. The increased consumption of amoxicillin/clavulanate and piperacillin/tazobactam was associated with the reduction of MRSA rate from 48.5 to 25.9% (p = 0.007 and p = 0.04, respectively). The increased consumption of piperacillin/tazobactam was associated with the reduction of ESBL-positive Enterobacteriaceae rate from 28.9 to 20.9% (p = 0.01). The increased consumption of carbapenems was associated with the increased rate of carbapenem-resistant Acinetobacter baumannii from 0 to 96.4% (p = 0.03). No carbapenem-resistant Enterobacteriaceae isolates were reported. The consumption of vancomycin grew significantly (p = 0.005). A dramatic spread of vancomycin-resistant Enterococcus faecium occurred in 2014. The consumption of fluoroquinolones and extended-spectrum cephalosporins remained stable.

Conclusions

An antibiotic stewardship program targeted to limit the consumption of extended-spectrum cephalosporins and fluoroquinolones in favor of amoxicillin/clavulanate and piperacillin/tazobactam correlates with a decreasing rate of MRSA and ESBL-positive Enterobacteriaceae. The analysis of correlations between antibiotic consumption and bacterial resistance rates is a useful tool to orient antimicrobial stewardship policies at local level.

Keywords

Antimicrobial resistance Antibiotic usage MRSA ESBLs Antibiotic stewardship 

Notes

Acknowledgements

The authors thank the members of the hospital Infection Control Committee of the University Hospital of Trieste, Italy, for their cooperation in the implementation of local guidelines of antibiotic therapy.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study was exempt for approval by our ethic committee because of the anonymous storage of data.

Funding

This study was not sponsored by external sources, no funding was received.

References

  1. 1.
    Tacconelli E, De Angelis G, Cataldo MA, et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother. 2009;53:4264–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Macedo-Viñas M, De Angelis G, Rohner P, et al. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect. 2013;84:132–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health care and economic outcomes. Clin Infect Dis. 2003;36:1433–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Sedláková MH, Urbánek K, Vojtová V, et al. Antibiotic consumption and its influence on the resistance in Enterobacteriaceae. BMC Res Notes. 2014;7:454.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2014. Oslo; 2014. http://www.sifac.it/sites/default/files/dice1838.pdf. Accessed 07 July 2015.
  6. 6.
    The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0; 2015. http://www.eucast.org/clinical_breakpoints/. Accessed 08 July 2015.
  7. 7.
    Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbial Infect. 2012;18:268–81.CrossRefGoogle Scholar
  8. 8.
    Bitterman R, Hussein K, Leibovici L, et al. Systematic review of antibiotic consumption in acute care hospitals. Clin Microbiol Infect. 2016;22:561.e7–562.e19.CrossRefGoogle Scholar
  9. 9.
    European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. http://ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-europe-2014.pdf. Accessed 07 July 2015.
  10. 10.
    Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in French University hospital. Clin Infect Dis. 2003;36:971–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008;61:26–38.CrossRefPubMedGoogle Scholar
  12. 12.
    Aldeyab MA, Monnet DL, López-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008;62:593–600.CrossRefPubMedGoogle Scholar
  13. 13.
    Prieto J, Aguilar L, Giménez MJ, et al. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin. Antimicrob Agents Chemother. 1998;42:1574–7.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Weber SG, Gold HS, Hooper DC, et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9:1415–22.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Joseph NM, Bhanupriya B, Shewade DG, Harish BN. Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates. J Clin Diagn Res. 2015;9:DC08–12.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Lai CC, Wang CY, Chu CC, et al. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother. 2011;66:1374–82.CrossRefPubMedGoogle Scholar
  17. 17.
    Livermore DM, Hope R, Reynolds R, et al. Declining cephalosporin and fluoroquinolone non susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother. 2013;68:2667–74.CrossRefPubMedGoogle Scholar
  18. 18.
    Bantar C, Vesco E, Heft C, et al. Replacement of broad-spectrum cephalosporins by piperacillin/tazobactam: impact on sustained high rates of bacterial resistance. Antimicrob Agents Chemother. 2004;48:392–5.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, et al. A multinational, preregistered cohort study of β-Lactam/β-Lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-Lactamase-producing enterobacteriace. Antimicrob Agents Chemother. 2016;60:4159–69.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii a case control study. Antimicrob Agents Chemother. 2004;48:224–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Su CH, Wang JT, Hsiung CA, et al. Increase of carbapenem- resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One. 2012;7:e37788.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Milan A, Furlanis L, Cian F, et al. Epidemic dissemination of a carbapenem-resistant Acinetobacter baumannii clone carrying armA two years after its first isolation in an Italian hospital. Microb Drug Resist. 2016;22:668–74.CrossRefPubMedGoogle Scholar
  23. 23.
    Chen IL, Lee CH, Su LH, et al. Antibiotic consumption and healthcare—associated infections caused by multidrug-resistant gram negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship. PLoS One. 2013;8:e65621.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    McLaughlin M, Advincula MR, Malczynski M, et al. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother. 2013;57:5131–3.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Lepper PM, Grusa E, Reichl H, et al. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002;46:2920–5.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Grau S, Fondevilla E, Freixas E, et al. Relationship between consumption of MRSA-active antibiotics and burden of MRSA in acute care hospitals in Catalonia. Spain J Antimicrob Chemother. 2015;70:1193–7.PubMedGoogle Scholar
  27. 27.
    Meyer E, Schwab F, Schroeren-Boersch B, et al. Increasing consumption of MRSA-active drugs without increasing MRSA in German ICUs. Intensive Care Med. 2011;37:1628–32.CrossRefPubMedGoogle Scholar
  28. 28.
    Forstner C, Diab-Elschahawi M, Kivaranovic D, et al. Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting. Antimicrob Resist Infect Control. 2015;4:25.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Kolar M, Urbanek K, Vagnerova I, et al. The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci. J Clin Pharm Ther. 2006;31:67–72.CrossRefPubMedGoogle Scholar
  30. 30.
    Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51–77.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Marta Mascarello
    • 1
  • Omar Simonetti
    • 1
  • Anna Knezevich
    • 2
  • Ludovica Ilaria Carniel
    • 3
  • Jacopo Monticelli
    • 1
  • Marina Busetti
    • 2
  • Paolo Schincariol
    • 3
  • Lucio Torelli
    • 4
  • Roberto Luzzati
    • 1
    • 4
  1. 1.Infectious Diseases UnitUniversity HospitalTriesteItaly
  2. 2.Microbiology UnitUniversity HospitalTriesteItaly
  3. 3.PharmacyUniversity HospitalTriesteItaly
  4. 4.Department of Medicine, Surgery and Health SciencesUniversity of TriesteTriesteItaly

Personalised recommendations